Purpose: Lithium is an essential treatment in bipolar disorder and treatment-resistant depression; however, its use has been limited by concerns regarding its renal adverse effects. An improved understanding of potential molecular mechanisms can help develop prevention and treatment strategies for lithium-associated renal disease.
Methods: We conducted a systematic literature search using MEDLINE, Embase, and PsychINFO including English-language original research articles published prior to November 2015 that specifically investigated lithium's effects on nephrogenic diabetes insipidus (NDI) and chronic kidney disease (CKD), using molecular markers.
Results: From a total of 3510 records, 71 pre-clinical studies and two relevant clinical studies were identified. Molecular alterations were reported in calcium signaling, inositol monophosphate, extracellular-regulated, prostaglandin, sodium/solute transport, G-protein-coupled receptors, nitric oxide, vasopressin/aquaporin, and inflammation-related pathways in lithium-associated renal disease. The majority of studies found that these mechanisms were implicated in NDI, while few studies had examined CKD.
Discussion: Future studies will have to focus on (1) validating the present findings in human subjects and (2) examining CKD, which is the most clinically relevant lithium-associated renal effect. This will improve our understanding of lithium's biological effects, as well as inform a personalized medicine approach, which could lead to safer lithium prescribing and less renal adverse events.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11255-016-1352-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Lithium-Associated Kidney Failure: Predictors and Outcomes.
Kidney Int Rep
May 2024
Department of Renal Medicine, Westmead Hospital, Sydney, New South Wales, Australia.
Introduction: Despite the widespread use of lithium for bipolar disorders and depression, little is known about the characteristics of patients with lithium-associated kidney failure receiving kidney replacement therapy (KRT).
Methods: We conducted a retrospective study using the Australian and New Zealand Dialysis and Transplant Registry (ANZDATA) to investigate the predictors and outcomes of patients with lithium-associated kidney failure receiving KRT.
Results: A total of 437 patients with lithium-associated kidney failure were compared to 1280 ANZDATA allocated controls of patients with kidney failure not associated with lithium.
Lithium-induced nephropathy; One medication with multiple side effects: a case report.
BMC Nephrol
September 2022
Sparrow Medical Group, Sparrow Hospital, 1200 E. Michigan ave, Michigan-48912, Lansing, United States.
Article Synopsis
- Lithium carbonate is widely used to treat bipolar disorder but has several known side effects, including a rare condition called minimal change disease, which affects kidney function.
- A case study details a 66-year-old man who developed minimal change disease and chronic tubulointerstitial nephropathy after 20 years of lithium therapy, presenting with severe swelling and reduced urine output.
- Despite stopping lithium and undergoing treatment, including steroids, his condition did not improve over 6 months, highlighting the potential long-term risks of long-term lithium use on kidney health.
Hemodialysis Treatment for Patients with Lithium Poisoning.
Int J Environ Res Public Health
August 2022
College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
Background: Hemodialysis is often recommended to treat severe lithium poisoning. Nevertheless, the application rate of hemodialysis in patients with lithium poisoning is varied across different groups and the effect of hemodialysis is still undetermined. Therefore, this study aimed to analyze the hemodialysis rate of patients with lithium poisoning and to explore the clinical features of lithium-poisoned-patients treated or untreated with hemodialysis.
View Article and Find Full Text PDFRelation of hyperparathyroidism and hypercalcemia to bipolar and psychotic disorders.
Proc (Bayl Univ Med Cent)
April 2022
Department of Psychiatry, Houston Methodist Hospital, Houston, Texas.
Primary hyperparathyroidism (PHPT) is characterized by hypercalcemia and an elevated level of serum parathyroid hormone. PHPT leads to hypercalcemia and presents with renal, skeletal, and neuropsychiatric symptoms. Neuropsychiatric manifestations of PHPT such as psychotic, depressive, and anxiety disorders are rare.
View Article and Find Full Text PDFMRI-based kidney radiomic analysis during chronic lithium treatment.
Eur J Clin Invest
May 2022
Explorations Fonctionnelles, Physiologie, APHP.Nord Hôpital Bichat, Paris, France.
Background: Lithium therapy during bipolar disorder is associated with an increased risk of chronic kidney disease (CKD) that is slowly progressive and undetectable at early stages. We aimed at identifying kidney image texture features as possible imaging biomarkers of decreased measured glomerular filtration rate (mGFR) using radiomics of T2-weighted magnetic resonance imaging (MRI).
Methods: One hundred and eight patients treated with lithium were evaluated including mGFR and kidney MRI, with T2-weighted sequence single-shot fast spin-echo.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!